Factors Associated With Nonadherence to S-1 in Docetaxel+S-1(DS) Therapy, an Adjuvant Treatment for Gastric Cancer
Information on S-1 nonadherence was revealed by conducting an oncology pharmacist outpatient clinic. Improved side-effect management and medication support is expected to contribute to reducing nonadherence in the future.
Authors
- Takashi Yokokawa (ORCID: https://orcid.org/0000-0001-9988-128X)
- Makoto Hiraide (ORCID: https://orcid.org/0000-0002-5243-9926)
- Kazuyoshi Kawakami (ORCID: https://orcid.org/0000-0003-2023-1300)
- Takeshi Aoyama (ORCID: https://orcid.org/0000-0002-0767-2606)
- Masahiro Hatori (ORCID: https://orcid.org/0000-0002-5914-504X)
- Daisuke Takahari (ORCID: https://orcid.org/0000-0002-2492-6014)
- Kenji Kobayashi (ORCID: https://orcid.org/0000-0002-6669-8830)
- Kensei Yamaguchi (ORCID: https://orcid.org/0000-0001-6887-5709)
- Hisanori Shimizu (ORCID: https://orcid.org/0000-0002-5623-6464)
- Kenichi Suzuki
- WATARU SUZUKI
- YUKA KIMURA
- MASAKAZU YAMAGUCHI
- MASASHI NAKAMURA
Institutions
- Tokyo University of Pharmacy and Life Sciences (JP)
- Japanese Foundation For Cancer Research (JP)
Publication Details
- Journal
- Anticancer Research
- Published
- 2026-03-27
- DOI
- https://doi.org/10.21873/anticanres.18114
- Primary Topic
- Safe Handling of Antineoplastic Drugs
- Type
- article
- Field-Weighted Citation Impact
- 0.00